Health / Health News

    Experimental Cat Allergy Therapy Gives More Effective Relief

    Researchers are testing a new way to treat people with allergies. The method uses regular allergy shots plus a lab-made molecule. The molecule blocks substances involved in allergic reactions in the body. For people with cat allergies, the combination therapy gave more effective relief than allergy shots alone.



    Experimental Cat Allergy Therapy Gives More Effective Relief. Photo: Hananeko_Studio/Shutterstock


    When you breathe in high amounts of a substance you’re allergic to—such as pollen, mold, pet dander, or dust mites—the resulting reactions in the nose are called allergic rhinitis.

    You may develop a stuffy, runny, and itchy nose as well as sneezing. These problems are caused by the body’s disease defenses reacting to something that’s harmless for most people.

    Some people get allergy shots to reduce these reactions. The shots gradually expose them to higher doses of the substance they’re allergic to.

    This can train the body’s defenses not to react when these things are in the air. Unfortunately, allergy shots don’t work for every-one. And the shots usually need to be given for at least three years.

    To test the new treatment, an National Institutes of Health-funded research team studied 121 adults with cat allergies. Some participants received allergy shots alone. Others received the new combination treatment. Treatments lasted nearly a year.

    By the time the treatments ended, both groups had improved. But when exposed to cat proteins, those given the experimental combination therapy had fewer symptoms than people given allergy shots alone.

    A year after the treatments were stopped, the effects from the standard allergy shots started wearing off. But the experimental treatment was still working to reduce symptoms.

    Researchers are continuing to study how the treatment works. They also plan to test and see if the approach might help to treat food allergies. (National Institutes of Health)

    JANUARY 12, 2023



    YOU MAY ALSO LIKE

    Study links very dry and very humid indoor environments with worse COVID-19 outcome.
    A research team has developed a new approach to better understand the biology of polycystic kidney disease (PKD), an often-life-threatening genetic disorder that affects millions worldwide.
    Moderate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas, a study has found.
    Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients.
    Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an approach that could be used to develop a new generation of antiviral drugs.
    Researchers at Penn State have successfully 3D bioprinted breast cancer tumors and treated them in a breakthrough study.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact